Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Zuberbier

Showing results (51-60 of 423) with videos related to

Pageof 43
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 18, 2012
Specific immunotherapy with allergens: an important tool in the treatment of the allergic diseasesTorsten Zuberbier, Giorgio Walter Canonica, Barbara da Silva
The Journal of Allergy and Clinical Immunology. in Practice|December 22, 2024
Urban Greening and Pollen Allergy: Balancing Health and Environmental SustainabilityKatarina Stevanovic, Aki Sinkkonen, Ruby Pawankar, et al.
Allergy|March 13, 2026
Legends of Allergology/Immunology: Marcus Maurer (†)-Physician, Scientist, Allergist and Unbeatable CommunicatorLudger Klimek, Martin Metz, Petra Staubach, et al.
Experimental Dermatology|September 28, 2016
Skin mast cell phenotypes between two highly divergent cohorts - more pronounced variability within than between groupsMagda Babina, Sven Guhl, Metin Artuc, et al.
The Journal of Allergy and Clinical Immunology|June 5, 2007
Successful treatment of cutaneous mastocytosis and Ménière disease with anti-IgE therapyFrank Siebenhaar, Wolfgang Kühn, Torsten Zuberbier, et al.
The Journal of Investigative Dermatology|July 30, 2021
Cytokine Stimulation by MRGPRX2 Occurs with Lower Potency than by FcεRI Aggregation but with Similar Dependence on the Extracellular Signal-Regulated Kinase 1/2 Module in Human Skin Mast CellsZhao Wang, Kristin Franke, Torsten Zuberbier, et al.
International Journal of Molecular Sciences|April 3, 2021
Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2Kristin Franke, Zhao Wang, Torsten Zuberbier, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 12, 2018
Chronische Urtikaria - Was bringt die neue Leitlinie?Marcus Maurer, Torsten Zuberbier, Frank Siebenhaar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2015
Omalizumab in the treatment of aspirin-exacerbated respiratory diseaseKarl-Christian Bergmann, Torsten Zuberbier, Martin K Church
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 9, 2026
Google searches show persistent use of outdated terminology for angioedema in GermanySophia Neisinger, Thomas Buttgereit, Torsten Zuberbier, et al.
Pageof 43

Showing results (51-60 of 423) with videos related to

Sort By:
Pageof 43
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 18, 2012
Specific immunotherapy with allergens: an important tool in the treatment of the allergic diseasesTorsten Zuberbier, Giorgio Walter Canonica, Barbara da Silva
The Journal of Allergy and Clinical Immunology. in Practice|December 22, 2024
Urban Greening and Pollen Allergy: Balancing Health and Environmental SustainabilityKatarina Stevanovic, Aki Sinkkonen, Ruby Pawankar, et al.
Allergy|March 13, 2026
Legends of Allergology/Immunology: Marcus Maurer (†)-Physician, Scientist, Allergist and Unbeatable CommunicatorLudger Klimek, Martin Metz, Petra Staubach, et al.
Experimental Dermatology|September 28, 2016
Skin mast cell phenotypes between two highly divergent cohorts - more pronounced variability within than between groupsMagda Babina, Sven Guhl, Metin Artuc, et al.
The Journal of Allergy and Clinical Immunology|June 5, 2007
Successful treatment of cutaneous mastocytosis and Ménière disease with anti-IgE therapyFrank Siebenhaar, Wolfgang Kühn, Torsten Zuberbier, et al.
The Journal of Investigative Dermatology|July 30, 2021
Cytokine Stimulation by MRGPRX2 Occurs with Lower Potency than by FcεRI Aggregation but with Similar Dependence on the Extracellular Signal-Regulated Kinase 1/2 Module in Human Skin Mast CellsZhao Wang, Kristin Franke, Torsten Zuberbier, et al.
International Journal of Molecular Sciences|April 3, 2021
Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2Kristin Franke, Zhao Wang, Torsten Zuberbier, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 12, 2018
Chronische Urtikaria - Was bringt die neue Leitlinie?Marcus Maurer, Torsten Zuberbier, Frank Siebenhaar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2015
Omalizumab in the treatment of aspirin-exacerbated respiratory diseaseKarl-Christian Bergmann, Torsten Zuberbier, Martin K Church
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 9, 2026
Google searches show persistent use of outdated terminology for angioedema in GermanySophia Neisinger, Thomas Buttgereit, Torsten Zuberbier, et al.
Pageof 43